ClinicalTrials.Veeva

Menu

Detection of Valvular Heart Disease Using Artificial Intelligence-based Stethoscope

X

Xiao-dong Zhuang

Status

Enrolling

Conditions

Valvular Heart Disease

Treatments

Other: artificial intelligence-based stethoscope

Study type

Observational

Funder types

Other

Identifiers

NCT06386016
Stethoscope study

Details and patient eligibility

About

The aim of this study is to develop a deep learning-based application of heart sounds in the diagnosis of valvular heart disease, which can be used to screen patients with valvular heart disease and promote earlier clinical monitoring and intervention.

Enrollment

2,000 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. age>18 years
  2. In the past 1 month, echocardiography was performed to diagnose valvular heart disease (positive group) and echocardiography to exclude valvular heart disease (negative group).
  3. Consent to study and be able to sign informed consent

Exclusion criteria

  1. After prosthetic valve replacement
  2. Congenital heart disease (except bilobal aortic valve)
  3. Hypertrophic Cardiomyopathy(HCM)
  4. Pregnant, lactating women

Trial design

2,000 participants in 2 patient groups

patients with valvular heart disease
Treatment:
Other: artificial intelligence-based stethoscope
patients without valvular heart disease
Treatment:
Other: artificial intelligence-based stethoscope

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems